Establishing secure connection…Loading editor…Preparing document…

Non-Exclusive License Agreement for Exploitation of a Secret Process

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Non-Exclusive License Agreement for Exploitation of a Secret Process

Agreement made on the day of , 20,

between (Name of Corporation), a corporation organized and existing under the laws of the state of , with its principal office located at

(street address, city, county, state, zip code), referred to herein as Owner, and (Name of Corporation), a corporation organized and existing under the laws of the state of , with its principal office located at

(street address, city, county, state, zip code), referred to herein as Manufacturer.

Whereas, Owner has the exclusive knowledge, possession, and ownership of certain processes (collectively, the Process), which Process may be generally described as (describe Process)

on a limited scale; and

Whereas, Manufacturer desires to manufacture and sell in profitable quantities, but it cannot do so without first obtaining the right to use the Process; and

Whereas, Owner is willing to grant such rights as Manufacturer requires on the terms set forth in this Agreement;

Now, therefore, for and in consideration of the mutual covenants contained in this agreement, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:

1. Use of Process

Owner grants to manufacturer the non-exclusive right to use the process in the manufacture of and such other products as the parties may agree on from time to time. Owner will fully instruct and advise employees of Manufacturer in all aspects of the Process and in the practical application and use of the Process. From now on, Owner will devote to improvement and further development of the Process such time and effort as may be necessary for maximum feasible exploitation of the Process.

2. Warranty of Owner

Owner covenants and warrants that at no time previously has it imparted to anyone any part of the Process, that no person now has any knowledge obtained through Owner in regard to the same, and that it will at all times preserve the secrecy of the same.

3. Royalties

As consideration for the rights granted under this Agreement, Manufacturer will pay to Owner royalties according to the following schedule:

A. For an initial period ending , % of the net selling price of all and other products manufactured and sold pursuant to this Agreement;

B. Subsequently, % of the net selling price of all and other products manufactured and sold pursuant to this Agreement.

C. Accrued royalties shall be paid on the day of each month. For purposes of this Agreement, "net selling price" means (define)

D. Regardless of output and sales, the minimum royalty payable to Owner during the term of this Agreement shall be $ per month.

4. Best Efforts

Manufacturer shall begin manufacture and sale of , and such other products as are agreed on, without undue delay. It will devote its best efforts to establishing and expanding a market for the various products manufactured pursuant to this Agreement.

5. Accounting

Manufacturer shall keep complete and accurate records of all transactions relative to products manufactured and sold pursuant to this Agreement, and shall render statements to Owner on request. For the purpose of verifying such statements, Owner shall have the right to examine the books and records of Manufacturer relative to the transactions. Such examinations may be made at any time during regular business hours.

6. Owner’s Covenant Not to Compete

As long as this Agreement is in force, Owner will not engage in any manner in the Manufacture of products the same as or essentially similar to products manufactured and sold by Manufacturer pursuant to this Agreement.

7. Duration of Agreement; Termination

This Agreement shall continue in force until . At the end of the initial term, the Agreement may be extended by mutual agreement of the parties, and if either party elects not to extend the term, the Agreement will terminate on the above-mentioned date.

8. Confidential Information.

Confidential Information in this Agreement shall mean all information and any idea in whatever form, tangible or intangible, whether disclosed to or learned by the Manufacturer, pertaining in any manner to the business of the Owner, whether in written, oral, encoded, graphic, magnetic, electronic or in any other tangible or intangible form, and whether or not labeled as confidential by the Owner or otherwise provided by the Manufacturer. Confidential Information includes, without limitation, the following: (a) schematics, techniques, employee suggestions, development tools and processes, computer printouts, computer programs, design drawings and manuals, and improvements; (b) information about costs, profits, markets and sales; (c) plans for future development and new product concepts; and (d) all documents, books, papers, drawings, models, sketches, and other data of any kind and description, including electronic data recorded or retrieved by any means, that have been or will be given to the Manufacturer by the Owner, as well as written or verbal instructions or comments.

9. Non-Disclosure.

Manufacturer shall hold all Confidential Information in strict confidence and shall not disclose any Confidential Information to any third party, without the prior written approval of the Owner. Manufacturer shall disclose Confidential Information only to employees who need to know such information and who have signed agreements that obligate them to treat Confidential Information as required under this Agreement. Manufacturer shall take all reasonable measures to protect the confidentiality and avoid the unauthorized use, disclosure, publication, or dissemination of Confidential Information; provided, however, that such measures shall be no less stringent than measures taken to protect its own confidential and proprietary information. Manufacturer acknowledges that the Owner is neither responsible nor liable for any business decisions made by the Manufacturer in reliance upon any Confidential Information disclosed pursuant hereto.

10. Remedies.

Manufacturer agrees that the unauthorized disclosure or use of Confidential Information will cause irreparable harm and significant injury, which may be difficult to ascertain. The Manufacturer recognizes that its violation of this Agreement could cause the Owner irreparable harm and significant injury, the amount of which may be extremely difficult to estimate, thus, making any remedy at law or in damages inadequate. Therefore, the Manufacturer agrees that the Owner shall have the right to apply to any court of competent jurisdiction for an order restraining any breach or threatened breach of this Agreement and for any other relief the Owner deems appropriate. This right shall be in addition to any other remedy available to the Owner in law or equity.

11. Non-Circumvent Agreement

Manufacturer agrees not to disclose, reveal or make use of any information revealed during discussion or observation of the Process regarding methods, concepts, ideas, product/services, or proposed new products or services without the written consent of the Owner.

12. No Waiver

The failure of either party to this Agreement to insist upon the performance of any of the terms and conditions of this Agreement, or the waiver of any breach of any of the terms and conditions of this Agreement, shall not be construed as subsequently waiving any such terms and conditions, but the same shall continue and remain in full force and effect as if no such forbearance or waiver had occurred.

13. Governing Law

This Agreement shall be governed by, construed, and enforced in accordance with the laws of the State of .

14. Notices

Any notice provided for or concerning this Agreement shall be in writing and shall be deemed sufficiently given when sent by certified or registered mail if sent to the respective address of each party as set forth at the beginning of this Agreement.

15. Attorney’s Fees

In the event that any lawsuit is filed in relation to this Agreement, the unsuccessful party in the action shall pay to the successful party, in addition to all the sums that either party may be called on to pay, a reasonable sum for the successful party's attorney fees.

16. Mandatory Arbitration

Any dispute under this Agreement shall be required to be resolved by binding arbitration of the parties hereto. If the parties cannot agree on an arbitrator, each party shall select one arbitrator and both arbitrators shall then select a third. The third arbitrator so selected shall arbitrate said dispute. The arbitration shall be governed by the rules of the American Arbitration Association then in force and effect.

17. Entire Agreement

This Agreement shall constitute the entire agreement between the parties and any prior understanding or representation of any kind preceding the date of this Agreement shall not be binding upon either party except to the extent incorporated in this Agreement.

18. Modification of Agreement

Any modification of this Agreement or additional obligation assumed by either party in connection with this Agreement shall be binding only if placed in writing and signed by each party or an authorized representative of each party.

19. Assignment of Rights

The rights of each party under this Agreement are personal to that party and may not be assigned or transferred to any other person, firm, corporation, or other entity without the prior, express, and written consent of the other party.

20. Counterparts

This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all of which together shall constitute but one and the same instrument.

WITNESS our signatures as of the day and date first above stated.

By

By

Enter text✕

What this non-exclusive license covers

A Non-Exclusive License Agreement for Exploitation of a Secret Process grants one or more licensees the right to use, manufacture, sell, or otherwise exploit a proprietary method or process while the licensor retains ownership and can grant identical rights to others. It describes the licensed scope, territory, permitted uses, duration, compensation, confidentiality obligations, and any limitations on sublicensing. This agreement differs from exclusive grants by preserving licensor freedom to license to additional parties and by requiring clear terms for confidentiality, trade secret protection, and remedies for misappropriation.

Why a tailored non-exclusive license matters

A clear non-exclusive license balances commercial access with owner control: it enables revenue or market entry while preserving the licensor's ability to further exploit and relicense the same secret process to multiple parties under defined terms.

Why a tailored non-exclusive license matters

Who typically prepares or signs this agreement

Legal, commercial, and technical stakeholders often collaborate when drafting and reviewing a non-exclusive license for a secret process.

  • Corporate licensing teams negotiating commercial terms and royalties for multiple partners.
  • In-house counsel and outside IP attorneys ensuring enforceable confidentiality and assignment provisions.
  • Manufacturers or service providers seeking limited rights to use a proprietary process commercially.

Signers should confirm authority, verify trade secret protections, and coordinate any required approvals before execution.

Primary signer roles

Licensor — Authorized Officer

Typically a corporate officer or authorized agent with delegated authority to grant licenses and bind the licensor. The signer should confirm board or corporate authorizations and ensure trade secret ownership and provenance are documented.

Licensee — Company Representative

An executive or contracting officer authorized to accept licensing terms on behalf of the licensee. The signer must confirm capacity to comply with confidentiality, recordkeeping, and royalty reporting obligations.

Essential clauses to include

A professional agreement combines precise scope language, enforceable confidentiality, compensation mechanics, and clear performance and termination provisions to reduce dispute risk and preserve trade secret protection.

Grant of Rights

Describe permitted acts (manufacture, use, sell), geographic territory, exclusivity level, sublicensing permissions, and any field-of-use restrictions in precise, narrowly tailored language.

Term and Renewal

Specify start date, fixed duration or triggers, renewal conditions, and whether term extensions require written amendment or automatic renewal.

Compensation

Set royalty rates, minimums, payment schedules, audit rights, reporting obligations, currency, and consequences for late payments.

Confidentiality

Define confidential information and trade secret status, set handling and protection standards, and include remedies for unauthorized disclosure or reverse engineering.

IP Ownership

Confirm licensor ownership of the secret process, state that no ownership transfers occur, and address improvements and joint developments.

Termination & Remedies

List termination events, cure periods, post-termination use restrictions, injunctive relief options, and survival of key provisions.

Required administrative items

Parties: Full legal names
Effective Date: MM/DD/YYYY format
Scope: Detailed field-of-use
Territory: Countries or regions
Compensation: Royalties or fees
Signatures: Names, titles, dates

Step-by-step: completing and executing the agreement

Follow a structured sequence to draft, review, approve, and execute the non-exclusive license to avoid omissions and preserve trade secret status.

  • 01
    Prepare Draft: Draft precise scope, payment, and confidentiality clauses.
  • 02
    Internal Review: Obtain legal and technical sign-off.
  • 03
    Negotiate Terms: Agree on royalties, limits, and remedies.
  • 04
    Execute: All parties sign and retain copies.

Typical execution and distribution flow

Execution workflows should track approvals, signatures, and distribution while creating an immutable audit trail for recordkeeping and enforcement.

  • Drafting: Create master agreement draft and exhibits.
  • Approval: Collect internal approvals and redlines.
  • Signing: Execute by authorized signatories.
  • Archival: Store executed copies in secure records.

Configuring a digital signing workflow

Set up an eSigning workflow that enforces signer order, identity checks, and the storage of a signed certificate and audit trail.

Field Configuration
Signer Order Specify signing sequence and required approvers
Authentication Choose email, SMS, or stronger authentication
Attachment Rules Require annexes or exhibits to be included
Retention Policy Set storage duration and access controls

Digital signature and platform considerations

Use a platform that preserves an auditable certificate of completion and supports required authentication for signers.

  • File Formats: PDF and DOCX supported
  • Integrations: Connect to document repositories and CRMs
  • Authentication: Email, SMS, KBA, or stronger methods

Confirm the platform meets legal and industry compliance needs, supports audit trails, and securely stores executed copies for the required retention period.

Key timing and deadline considerations

Track essential dates for effectiveness, reporting, payments, renewal notice, and any milestones tied to compensation or performance.

Effective Date Entry:

Record the signed effective date in MM/DD/YYYY format

Payment Schedules:

Note due dates for royalties and milestone payments

Renewal Notices:

Calendar any required notice periods for renewal or nonrenewal

Audit Windows:

Track periods during which royalty audits may be exercised

Termination Notices:

Observe cure periods and notice delivery requirements

Milestones from negotiation to enforcement

A sequential milestone timeline clarifies responsibilities and expected timing for each stage of the licensing lifecycle.

01

Draft Completion

Finalize the initial agreement draft and exhibits.

02

Review Cycle

Complete legal and technical reviews and record approvals.

03

Execution

Obtain signatures and distribute certified copies.

04

Post-Execution Compliance

Implement confidentiality controls and royalty reporting.

Common drafting and negotiation pitfalls

  • Overbroad scope language that unintentionally permits uses the licensor did not intend, increasing competitive risk and complicating enforcement.
  • Vague definitions for 'secret process' or 'improvements' that lead to disputes over what is included or excluded from the licensed rights.
  • Insufficient confidentiality protocols or failure to require reasonable technical safeguards, risking disclosure and loss of trade secret protection.
  • Missing audit or reporting rights, which prevent licensors from verifying royalty compliance and detecting underreporting promptly.

Consequences of defective or incomplete agreements

Enforceability Risk: Court may limit or void ambiguous grants
Loss of Trade Secret: Public disclosure can forfeit protection
Financial Loss: Unpaid royalties and recovery challenges
Injunction Delays: Remedies may be slow or unavailable
Recordkeeping Gaps: Audit failure or compliance penalties
Authority Issues: Signatures without authority may be invalid

eSignature vendor comparison for licensing workflows

Compare basic pricing and a few capability flags that commonly matter for licensing agreements. signNow is listed first per comparison conventions.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies Varies Varies Varies
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No
Envelope Cap No cap 100 envelopes/user/year Varies by plan Varies by plan Varies by plan

Use-case examples

Real-world examples show how parties structure non-exclusive licenses to protect secrets while enabling commercial use.

Manufacturing License

A mid-size manufacturer licensed Process X for production in North America

  • License limited to two product lines and territory
  • The licensor retained global rights, required quarterly royalty reports, and reserved audit rights to verify compliance and sales.

Clinical Method

A healthcare startup licensed a proprietary clinical process to an established provider

  • License restricted to non-commercial research use initially
  • A staged commercial license with confidentiality addenda and HIPAA-compliant data handling was implemented at commercialization.

Frequently asked questions

Answers to common questions on enforceability, signature methods, authority to sign, revocation, and recordkeeping for non-exclusive license agreements.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users